Xcout Intel
Variational AI competitors & alternatives
The 12 closest competitors and alternatives to Variational AI among drug discovery companies — ranked by similarity to what Variational AI actually does, not by market-cap band.
Subscribe to see Variational AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Variational AI
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Variational AI at a glance
Variational AI is a drug discovery company headquartered in Canada. It has raised at least $9M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $5.5M in February 2025. Xcout tracks 11 named people at Variational AI, including Handol Kim (CEO).
Variational AI leadership
- Handol KimCEO
- Handol KimCo-Founder & CEO
- Jason Rolfe, PhDCo-Founder & CTO
- Ali Saberali, PhDCo-Founder & Head of Platform
- Peter Guzzo, PhDEVP, Head of Drug Discovery
- Roslynn Drewitt-LangeVP, Finance & Operations
5 more named people on record for Variational AI, with roles, board committees and tenure — see the full roster →
Variational AI funding rounds
At least $9M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5.5M | 8 named | |
| — | $3.5M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Variational AI competitors
Ranked by semantic similarity — how close each company is to Variational AI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Iktos is a privately held biotechnology company headquartered in Paris, France, specializing in generative AI and robotics for drug discovery. Its generative AI platform, Makya, designs molecules optimized for robotic synthesis.
Similar drug discovery company
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Drug Delivery
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Similar drug discovery company
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Quantum Computing
Qubit Pharmaceuticals is a privately held company headquartered in Paris, France, that brings precision to drug discovery and design by utilizing cutting-edge quantum physics-based science to develop life-changing treatments.
Similar drug discovery company
Pharmacelera is a computational chemistry company based in Barcelona, Spain, that provides drug discovery services and solutions for biotech and pharmaceutical clients.
Similar drug discovery company
Curreio is a biotechnology company founded in 2019 and headquartered in Japan. It operates as a contract research organization (CRO) providing drug discovery and development support services utilizing high-resolution structural analysis with cryo-electron microscopy technology.
Computational Drug Discovery and Materials Science
Prescience Insilico provides AI-driven software platforms and R&D services for drug discovery and materials science innovation.
Similar drug discovery company
Kainova Therapeutics, formerly known as Domain Therapeutics, is a clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company drives a clinical pipeline of advanced GPCR-modulating therapies to address unmet medical needs.
Deeptech
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Variational AI and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Variational AIand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →